Pradžia › Ūmi bifeninė leukemija › Ilinoisas › Chicago

Ūmi bifeninė leukemija klinikiniai tyrimai Chicago, IL

7 tyrimai dėl Ūmi bifeninė leukemija ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Renkami dalyviai2 fazė

Lurie Children's Hospital-Chicago, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

365 Days · Visoms lytims · Atnaujinta 2026-09-25 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Renkami dalyviai1/2 fazė

The University of Chicago Medical Center, Chicago

30 Days · Visoms lytims · Atnaujinta 2026-09-16 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Renkami dalyviai3 fazė

Lurie Children's Hospital-Chicago, Chicago
University of Illinois, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

365 Days – 25 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Renkami dalyviai1/2 fazė

Lurie Children's Hospital-Chicago, Chicago
University of Illinois, Chicago
University of Chicago Comprehensive Cancer Center, Chicago

Iki 22 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT04726241

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Renkami dalyviai1/2 fazė

University of Illinois at Chicago Cancer Center, Chicago

Amžius nuo 12 iki 95 · Visoms lytims · Atnaujinta 2026-04-15 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Renkami dalyviai1 fazė

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago

Amžius nuo 1 iki 40 · Visoms lytims · Atnaujinta 2026-03-12 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Renkami dalyviai1 fazė

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2024-12-06 · NCT05476770

Ūmi bifeninė leukemija tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.